Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease

Asian J Androl. 2002 Sep;4(3):187-90.

Abstract

Aim: Erectile dysfunction may be observed in up to 80% of patients with Peyronie's disease. An objective evaluation of the erectile function is attempted to work out in patients with Peyronie's disease.

Methods: Penile deformity, sexual function and penile vascular status were analyzed in 123 patients with Peyronie's disease, who had not received any pertinent treatment.

Results: Penile deformity, palpable plaque and pain on erection were seen in 112 (91%), 97 (78.8%) and 27 (21.9%) of the 123 patients, respectively. Of the 76 patients evaluated by color Doppler ultrasounography, veno-occlusive dysfunction as the vascular component for erectile dysfunction was found in 17 (22.3%), arterial insufficiency in 10 (13.1%) and a mixed picture in 23 (30.2%).

Conclusion: The documentation of penile erectile function and the determination of the vascular status using color Doppler ultrasonography can guide the appropriate therapeutic choice.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antioxidants / therapeutic use
  • Colchicine / therapeutic use
  • Erectile Dysfunction / diagnostic imaging
  • Erectile Dysfunction / drug therapy
  • Erectile Dysfunction / physiopathology
  • Gout Suppressants / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Penile Induration / diagnostic imaging
  • Penile Induration / drug therapy*
  • Penile Induration / physiopathology*
  • Penis / blood supply*
  • Penis / pathology
  • Penis / physiopathology
  • Ultrasonography, Doppler, Color
  • Vitamin E / therapeutic use

Substances

  • Antioxidants
  • Gout Suppressants
  • Vitamin E
  • Colchicine